ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

NIEHS Director Olden Outlines Strategy For Carcinogenicity Testing

September 11, 1992

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

DCPTC Proceeding With Plans For Intramural Lab

January 30, 1987

Letter: Boy Has Little Chance At Cure Without Proven Treatments.

February 11, 2000

European Treatment Regimen Less Toxic Than American Method

April 26, 2013

Elderly Men Say Physicians Are Recommending PSA Tests

December 26, 2003